Literature DB >> 18076114

Retention of African American women in cancer genetics research.

Chanita Hughes Halbert1, Deja Love, Tynisha Mayes, Aliya Collier, Benita Weathers, Lisa Kessler, Jill Stopfer, Deborah Bowen, Susan Domchek.   

Abstract

Although retention is a critical component of longitudinal cancer genetics research, limited empirical data are available on predictors of study retention among populations that are difficult to enroll. We evaluated predictors of retention in cancer genetics research among African American women at increased risk for having a BRCA1 and BRCA2 (BRCA1/2) mutation. Participants were African American women (n = 192) at increased risk for hereditary breast-ovarian cancer who were enrolled in a longitudinal genetic counseling research study. Retention was evaluated separately for the 1- and 6-month follow-ups and in terms of overall retention (e.g., completion of both telephone interviews). Seventy-three percent of women and 65% of women were retained at the 1- and 6-month follow-ups respectively; in terms of overall retention, 60% of women were retained in both follow-up telephone interviews. Predictors of retention at 1-month included being employed (OR = 2.47, 95% CI = 1.24, 4.93, P = 0.01) whereas predictors of overall retention included having a personal history of breast and/or ovarian cancer (OR = 2.06, 95% CI = 1.07, 3.95, P = 0.03) and having completed genetic counseling (OR = 2.63, 95% CI = 1.39, 4.98, P = 0.003). These data suggest that once enrolled in genetic counseling research, the majority of African American women will continue to participate, especially if concrete clinical services are provided. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18076114     DOI: 10.1002/ajmg.a.32067

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  Intervention completion rates among African Americans in a randomized effectiveness trial for diet and physical activity changes.

Authors:  Chanita Hughes Halbert; Scarlett Bellamy; Vanessa Briggs; Marjorie Bowman; Ernestine Delmoor; Jerry C Johnson; Shiriki Kumanyika; Cathy Melvin; Joseph Purnell; Rodney Rogers; Benita Weathers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-22       Impact factor: 4.254

2.  Providers' perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American women.

Authors:  Kristi D Graves; Juleen Christopher; Toni Michelle Harrison; Beth N Peshkin; Claudine Isaacs; Vanessa B Sheppard
Journal:  J Genet Couns       Date:  2011-08-06       Impact factor: 2.537

3.  A cluster randomized controlled trial to increase breast cancer screening among African American women: the black cosmetologists promoting health program.

Authors:  Georgia Robins Sadler; Celine M Ko; Phillis Wu; Jennifer Alisangco; Sheila F Castañeda; Colleen Kelly
Journal:  J Natl Med Assoc       Date:  2011-08       Impact factor: 1.798

4.  Knowledge and accuracy of perceived personal risk in underserved women who are at increased risk of breast cancer.

Authors:  Mfon S Cyrus-David
Journal:  J Cancer Educ       Date:  2010-12       Impact factor: 2.037

5.  Low rates of African American participation in genetic counseling and testing for BRCA1/2 mutations: racial disparities or just a difference?

Authors:  Chanita Hughes Halbert; Lisa Kessler; Aliya Collier; Benita Weathers; Jill Stopfer; Susan Domchek; Jasmine A McDonald
Journal:  J Genet Couns       Date:  2012-07-12       Impact factor: 2.537

6.  Conducting Precision Medicine Research with African Americans.

Authors:  Chanita Hughes Halbert; Jasmine McDonald; Susan Vadaparampil; LaShanta Rice; Melanie Jefferson
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

7.  Challenges in recruiting African-American women for a breast cancer genetics study.

Authors:  Amanda J Compadre; Melinda E Simonson; Katy Gray; Gail Runnells; Susan Kadlubar; Kristin K Zorn
Journal:  Hered Cancer Clin Pract       Date:  2018-04-24       Impact factor: 2.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.